BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25660821)

  • 1. Geranylgeranylacetone protects against small-intestinal injuries induced by diclofenac in patients with rheumatic diseases: a prospective randomized study.
    Xiong L; Huang X; Li L; Yang X; Liang L; Zhan Z; Ye Y; Chen M
    Dig Liver Dis; 2015 Apr; 47(4):280-4. PubMed ID: 25660821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geranylgeranylacetone protects against diclofenac-induced gastric and small intestinal mucosal injuries in healthy subjects: a prospective randomized placebo-controlled double-blind cross-over study.
    Niwa Y; Nakamura M; Miyahara R; Ohmiya N; Watanabe O; Ando T; Kawashima H; Itoh A; Hirooka Y; Goto H
    Digestion; 2009; 80(4):260-6. PubMed ID: 19844108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of nonsteroidal anti-inflammatory drug-induced small-intestinal injury by prostaglandin: a pilot randomized controlled trial evaluated by capsule endoscopy.
    Fujimori S; Seo T; Gudis K; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    Gastrointest Endosc; 2009 Jun; 69(7):1339-46. PubMed ID: 19243767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine.
    Umegaki E; Kuramoto T; Kojima Y; Nouda S; Ishida K; Takeuchi T; Inoue T; Tokioka S; Higuchi K
    Intern Med; 2014; 53(4):283-90. PubMed ID: 24531083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
    Niwa Y; Nakamura M; Ohmiya N; Maeda O; Ando T; Itoh A; Hirooka Y; Goto H
    J Gastroenterol; 2008; 43(4):270-6. PubMed ID: 18458842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of small intestinal mucosal injuries as a result of NSAID administration.
    Fujimori S; Gudis K; Takahashi Y; Seo T; Yamada Y; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    Eur J Clin Invest; 2010 Jun; 40(6):504-10. PubMed ID: 20412292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
    Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of small bowel injury by switching from nonselective nonsteroidal anti-inflammatory drugs to celecoxib in rheumatoid arthritis patients: a pilot study.
    Inoue T; Iijima H; Arimitsu J; Hagihara K; Kawai S; Shiraishi E; Hiyama S; Mukai A; Shinzaki S; Nishida T; Ogata A; Tsujii M; Takehara T
    Digestion; 2014; 89(2):124-32. PubMed ID: 24526219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macroscopic small bowel mucosal injury caused by chronic nonsteroidal anti-inflammatory drugs (NSAID) use as assessed by capsule endoscopy.
    Caunedo-Alvarez A; Gómez-Rodríguez BJ; Romero-Vázquez J; Argüelles-Arias F; Romero-Castro R; García-Montes JM; Pellicer-Bautista FJ; Herrerías-Gutiérrez JM
    Rev Esp Enferm Dig; 2010 Feb; 102(2):80-5. PubMed ID: 20361843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsule endoscopic diagnosis of nonsteroidal antiinflammatory drug-induced enteropathy.
    Maiden L
    J Gastroenterol; 2009; 44 Suppl 19():64-71. PubMed ID: 19148796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irsogladine improves small-intestinal injuries in regular users of nonsteroidal anti-inflammatory drugs.
    Isomura Y; Yamaji Y; Yamada A; Watanabe Y; Suzuki H; Kobayashi Y; Yoshida S; Watabe H; Hirata Y; Yoshida H; Koike K
    Gastrointest Endosc; 2014 Jul; 80(1):118-25. PubMed ID: 24518124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effect of irsogladine or omeprazole on non-steroidal anti-inflammatory drug-induced esophagitis, peptic ulcers, and small intestinal lesions in humans, a prospective randomized controlled study.
    Kuramoto T; Umegaki E; Nouda S; Narabayashi K; Kojima Y; Yoda Y; Ishida K; Kawakami K; Abe Y; Takeuchi T; Inoue T; Murano M; Tokioka S; Higuchi K
    BMC Gastroenterol; 2013 May; 13():85. PubMed ID: 23672202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscovite is protective against non-steroidal anti-inflammatory drug-induced small bowel injury.
    Huang C; Lu B; Fan YH; Zhang L; Jiang N; Zhang S; Meng LN
    World J Gastroenterol; 2014 Aug; 20(31):11012-8. PubMed ID: 25152605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole increased small intestinal mucosal injury in two of six disease-free cases evaluated by capsule endoscopy.
    Fujimori S; Takahashi Y; Tatsuguchi A; Sakamoto C
    Dig Endosc; 2014 Sep; 26(5):676-9. PubMed ID: 25383403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.
    Maiden L; Thjodleifsson B; Theodors A; Gonzalez J; Bjarnason I
    Gastroenterology; 2005 May; 128(5):1172-8. PubMed ID: 15887101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of milk and milk products on non-steroidal anti-inflammatory drug induced intestinal damage in rats].
    Zhang S; Lü B; Chao GQ; Chen FM; Chen MY; Chen HQ
    Zhonghua Nei Ke Za Zhi; 2011 Sep; 50(9):771-5. PubMed ID: 22176967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proximal predominance of small bowel injury associated with uncoated low-dose aspirin therapy: a video capsule study in chronic users.
    Ehrhard F; Nazeyrollas P; Brixi H; Heurgue-Berlot A; Thiéfin G
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1265-72. PubMed ID: 23873021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
    Maiden L; Thjodleifsson B; Seigal A; Bjarnason II; Scott D; Birgisson S; Bjarnason I
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1040-5. PubMed ID: 17625980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effect of ecabet sodium on low-dose aspirin-induced small intestinal mucosal injury: a randomized, double-blind, pilot study.
    Ota K; Takeuchi T; Kojima Y; Harada S; Hirata Y; Sugawara N; Nouda S; Kakimoto K; Kuramoto T; Higuchi K
    BMC Gastroenterol; 2019 Jan; 19(1):4. PubMed ID: 30621622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.